Literature DB >> 140540

[Change of toxicity and carcinogenicity of N-methyl-N-nitrosobenzylamine in rats by methylsubstitution in the phenylresidue].

F Schweinsberg, P Schott-Kollat, G Bürkle.   

Abstract

Substitution with a methyl group in the 2-, 3- or 4-position respectively of the phenyl moiety of N-methyl-N-nitrosobenzylamine results in a considerable reduction of the acute toxicity. (LD 50 of MNBA: 18 mg/kg (Druckrey et al., 1967), 2-Me-MNBA: 90 mg/kg, 3-Me-MNBA: 600 mg/kg, 4-Me-MNBA: 400 mg/kg). However, the introduction of the methyl group influences the carcinogenic activity of MNBA in rats and its organotropy, only to a small extent. Long-term administration of 5 and 15 ppm respectively of the isomeric N-nitroso compounds in the drinking water produces in all animals carcinomas of the oesophagus and the pharynx.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140540     DOI: 10.1007/bf00305361

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  1 in total

1.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967
  1 in total
  3 in total

1.  [Change of toxicity and carcinogenicity of n-methyl-n-nitrosobenzylamine in rats by methylsubstitution at the c-atoms adjacent to nitrogen (author's transl)].

Authors:  F Schweinsberg; M Kouros; K Manncke; K Rieth
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-10-30

2.  [Comparative investigations on the organotropic carcinogenic effect of different N-nitroso compounds with rat after single and chronic treatment (author's transl)].

Authors:  F Schweinsberg; M Kouros; K Manncke
Journal:  J Cancer Res Clin Oncol       Date:  1979-10       Impact factor: 4.553

3.  QSAR and Classification Study on Prediction of Acute Oral Toxicity of N-Nitroso Compounds.

Authors:  Tengjiao Fan; Guohui Sun; Lijiao Zhao; Xin Cui; Rugang Zhong
Journal:  Int J Mol Sci       Date:  2018-10-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.